Bellus Health, Asclepios Bioresearch Ltd. deal

In its 3Q12 earnings, Bellus said that it and venture capital firm Asclepios partnered during the quarter to develop Bellus' BLU8499 (formerly NRM8499) to treat Alzheimer's disease. Asclepios will f...